Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2006, p. 617-629, Vol. 26, No. 2
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.2.617-629.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Laura N. Ozolins,1,
Srishti Bhagat,1
Gary P. Newnam,1
Renee D. Wegrzyn,1,
Michael Y. Sherman,2 and
Yury O. Chernoff1*
School of Biology and Institute for Bioengineering and Bioscience, Georgia Institute of Technology, M/C 0230, 310 Ferst Drive, Atlanta, Georgia 30332-0230,1 Department of Biochemistry, Boston University School of Medicine, K323, 715 Albany St., Boston, Massachusetts 021182
Received 3 June 2005/ Returned for modification 22 July 2005/ Accepted 31 October 2005
Self-perpetuating protein aggregates transmit prion diseases in mammals and heritable traits in yeast. De novo prion formation can be induced by transient overproduction of the corresponding prion-forming protein or its prion domain. Here, we demonstrate that the yeast prion protein Sup35 interacts with various proteins of the actin cortical cytoskeleton that are involved in endocytosis. Sup35-derived aggregates, generated in the process of prion induction, are associated with the components of the endocytic/vacuolar pathway. Mutational alterations of the cortical actin cytoskeleton decrease aggregation of overproduced Sup35 and de novo prion induction and increase prion-related toxicity in yeast. Deletion of the gene coding for the actin assembly protein Sla2 is lethal in cells containing the prion isoforms of both Sup35 and Rnq1 proteins simultaneously. Our data are consistent with a model in which cytoskeletal structures provide a scaffold for generation of large aggregates, resembling mammalian aggresomes. These aggregates promote prion formation. Moreover, it appears that the actin cytoskeleton also plays a certain role in counteracting the toxicity of the overproduced potentially aggregating proteins.
Present address: Institute of Biophysics, Krasnoyarsk 660036, Russia.
Present address: University of Toronto School of Medicine, Toronto, Ontario, Canada.
Present address: Zentrum für Molekulare Biologie der Universität Heidelberg, D-69120 Heidelberg, Germany.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|